Menu

Can-Fite BioPharma Ltd. CANF

Full chart Compare
Set alert

Price alert · CANF

All alert types
1.55 USD -0.11 (-6.63%)

At closeNov 12, 2026, 4:06 AM EST

1.60 +0.05 +3.23%

Pre-market · Nov 12, 4:06 AM ET

1.57 Day range 1.63
1.50 52-week range 12.40
YTD
-61.25%
1 year
-80.63%

CANF revenue history

Revenue is income from the company’s ordinary business activities.

405,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 2010: 713,880USDFY 2011: 481,950USDFY 2012: 0USDFY 2013: 0USDFY 2014: 0USDFY 2015: 162,000USDFY 2016: 165,000USDFY 2017: 789,000USDFY 2018: 3,820,000USDFY 2019: 2,032,000USDFY 2020: 763,000USDFY 2021: 853,000USDFY 2022: 810,000USDFY 2023: 743,000USDFY 2024: 674,000USDFY 2025: 405,000USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-31405,000-269,000-39.91%
FY 20242024-12-31674,000-69,000-9.29%
FY 20232023-12-31743,000-67,000-8.27%
FY 20222022-12-31810,000-43,000-5.04%
FY 20212021-12-31853,00090,00011.80%
FY 20202020-12-31763,000-1,269,000-62.45%
FY 20192019-12-312,032,000-1,788,000-46.81%
FY 20182018-12-313,820,0003,031,000384.16%
FY 20172017-12-31789,000624,000378.18%
FY 20162016-12-31165,0003,0001.85%
FY 20152015-12-31162,000162,000Not meaningful
FY 20142014-12-3100Not meaningful
FY 20132013-12-3100Not meaningful
FY 20122012-12-310-481,950-100.00%
FY 20112011-12-31481,950-231,930-32.49%
FY 20102010-12-31713,880Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-09-11T06:02:17.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.